hydrogen peroxide · Aclaris · NDA 209305
Eskata
Earliest generic entry, as listed
4 Jul 2035
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 9675639.
Listed patents · 5 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9675639 | drug product, use U-2205 · sets the listed date | 4 Jul 2035 |
| US 10098910 | drug product, use U-2205 | 21 Apr 2035 |
| US 10493103 | drug product | 21 Apr 2035 |
| US 10729720 | drug product | 21 Apr 2035 |
| US 9980983 | use U-2205 | 21 Apr 2035 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209305 · 001 · RLD · discontinued | solution, topical | 40% | 4 Jul 2035 |